AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32164544 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect experiences of cognitive disorders
Number of subjects: 15
Study 35772479 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-reported physical activity (PA)
Number of subjects: 122
Study 35772479 — intervention group
Group type: EXPERIMENTAL
Intervention: Children meeting the PROMIS-PA 'good' cutoff
Number of subjects: 122
Study 35772479 — intervention group
Group type: EXPERIMENTAL
Intervention: Children's age
Number of subjects: 122
Study 34456043 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic Manipulative Treatment (OMT)
Number of subjects: 20
Study 36239839 — intervention group
Group type: EXPERIMENTAL
Intervention: CB‐TDCS
Number of subjects: 60
Study 36239839 — intervention group
Group type: EXPERIMENTAL
Intervention: M1‐TDCS
Number of subjects: 60
Study 36239839 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 60
Study 33730652 — intervention group
Group type: EXPERIMENTAL
Intervention: pemetrexed/pembrolizumab/platinum
Number of subjects: 405
Study 33730652 — intervention group
Group type: COMPARATOR
Intervention: pemetrexed/placebo/platinum
Number of subjects: 405
Study 32417961 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy (ATE)
Number of subjects: 83
Study 32417961 — intervention group
Group type: COMPARATOR
Intervention: Adenopharyngoplasty (APP)
Number of subjects: 83
Study 33123781 — intervention group
Group type: EXPERIMENTAL
Intervention: Puncture needles
Number of subjects: 42
Study 33123781 — intervention group
Group type: COMPARATOR
Intervention: Rasps
Number of subjects: 42
Study 33123781 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 42
Study 36352610 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm and leg cycle ergometry along with conventional physiotherapy exercises
Number of subjects: 34
Study 36352610 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy exercises
Number of subjects: 34
Study 32710485 — intervention group
Group type: EXPERIMENTAL
Intervention: Postdivorce hostility levels
Number of subjects: 1856
Study 32710485 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of hostility levels between male and female divorcees
Number of subjects: 1856
Study 32710485 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictors of postdivorce hostility
Number of subjects: 1856
Study 35550109 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-minute running trial at -15°C
Number of subjects: 18
Study 35550109 — intervention group
Group type: EXPERIMENTAL
Intervention: 90-minute running trial at -15°C
Number of subjects: 18
Study 35690388 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (2 mA for 20 min, 15 daily sessions over 3 weeks)
Number of subjects: 120
Study 35690388 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 120
Study 35320401 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyphenol supplement (PPS) containing black tea powder, cocoa powder, and grape juice extract
Number of subjects: 14
Study 34101212 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal thiamine supplementation (10 mg/day)
Number of subjects: 335
Study 34101212 — intervention group
Group type: COMPARATOR
Intervention: Maternal thiamine supplementation (0 mg/day)
Number of subjects: 335
Study 34101212 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal thiamine supplementation (1.2 mg/day)
Number of subjects: 335
Study 34101212 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal thiamine supplementation (2.4 mg/day)
Number of subjects: 335
Study 35665277 — intervention group
Group type: EXPERIMENTAL
Intervention: Yishen Tiaodu acupuncture
Number of subjects: 62
Study 35665277 — intervention group
Group type: COMPARATOR
Intervention: Ordinary acupuncture
Number of subjects: 62
Study 32042600 — intervention group
Group type: COMPARATOR
Intervention: G‐only intervention (online intervention for gambling)
Number of subjects: 282
Study 32042600 — intervention group
Group type: EXPERIMENTAL
Intervention: G + A intervention (online gambling intervention plus a brief personalized feedback intervention for unhealthy alcohol use)
Number of subjects: 282
Study 35012796 — intervention group
Group type: EXPERIMENTAL
Intervention: Video instructions
Number of subjects: 60
Study 35012796 — intervention group
Group type: COMPARATOR
Intervention: Paper handout instructions
Number of subjects: 60
Study 33510561 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (mixed preparation of Bacillus subtilis and Enterococcus faecium)
Number of subjects: 128
Study 33510561 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study 33510561 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 128
Study 32089538 — intervention group
Group type: EXPERIMENTAL
Intervention: Sight word intervention for Deaf students (8-month duration)
Number of subjects: 30
Study 32089538 — intervention group
Group type: EXPERIMENTAL
Intervention: Sight word intervention for younger students
Number of subjects: 30
Study 36430133 — intervention group
Group type: EXPERIMENTAL
Intervention: DenseNet169 model
Number of subjects: 500
Study 36430133 — intervention group
Group type: EXPERIMENTAL
Intervention: MobileNetV3 model
Number of subjects: 500
Study 36430133 — intervention group
Group type: EXPERIMENTAL
Intervention: VGG19 model
Number of subjects: 500
Study 36430133 — intervention group
Group type: EXPERIMENTAL
Intervention: ResNet50 model
Number of subjects: 500
Study 36430133 — intervention group
Group type: EXPERIMENTAL
Intervention: VGG16 model
Number of subjects: 500
Study 36430133 — intervention group
Group type: EXPERIMENTAL
Intervention: AlexNet model
Number of subjects: 500
Study 34148161 — intervention group
Group type: EXPERIMENTAL
Intervention: XP‐endo Finisher (XPF)
Number of subjects: 64
Study 34148161 — intervention group
Group type: COMPARATOR
Intervention: Er,Cr: YSGG laser
Number of subjects: 64
Study 34148161 — intervention group
Group type: COMPARATOR
Intervention: Conventional endodontic needle (CEN)
Number of subjects: 64
Study 34148161 — intervention group
Group type: COMPARATOR
Intervention: EndoActivator (EA)
Number of subjects: 64
Study 35987678 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAID (ibuprofen)
Number of subjects: 44
Study 35987678 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 34233640 — intervention group
Group type: EXPERIMENTAL
Intervention: IRE (Irreversible electroporation)
Number of subjects: 528
Study 34233640 — intervention group
Group type: COMPARATOR
Intervention: SOC (Standard of Care)
Number of subjects: 528
Study 33806518 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT-based psychoeducation intervention (including mindfulness)
Number of subjects: 225
Study 33806518 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducation plus biofeedback intervention
Number of subjects: 225
Study 33806518 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 225
Study 35788072 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabeculectomy
Number of subjects: 88
Study 35788072 — intervention group
Group type: COMPARATOR
Intervention: Peripheral iridectomy plus ab interno goniotomy
Number of subjects: 88
Study 34169625 — intervention group
Group type: EXPERIMENTAL
Intervention: Dasiglucagon 0.6 mg
Number of subjects: 45
Study 34169625 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 32813861 — intervention group
Group type: EXPERIMENTAL
Intervention: High-monounsaturated fat meal (MUFA) (≈1000 kcal, 56.3% Energy from MUFA) with orange juice
Number of subjects: 39
Study 32813861 — intervention group
Group type: EXPERIMENTAL
Intervention: High-saturated fat meal (SFA) (≈1000 kcal, 37.6% Energy from SFA) with orange juice
Number of subjects: 39
Study 32813861 — intervention group
Group type: EXPERIMENTAL
Intervention: High-saturated fat meal (SFA) (≈1000 kcal, 37.6% Energy from SFA) with water
Number of subjects: 39
Study 32813861 — intervention group
Group type: EXPERIMENTAL
Intervention: High-monounsaturated fat meal (MUFA) (≈1000 kcal, 56.3% Energy from MUFA) with water
Number of subjects: 39
Study 35164686 — intervention group
Group type: EXPERIMENTAL
Intervention: PromeTheus program (home-based physical exercises and counseling services)
Number of subjects: 400
Study 35164686 — intervention group
Group type: COMPARATOR
Intervention: Usual care with a one-time counseling session
Number of subjects: 400
Study 35164686 — intervention group
Group type: EXPERIMENTAL
Intervention: PromeTheus program
Number of subjects: 400
Study 34724860 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided microwave ablation (MWA)
Number of subjects: 167
Study 34724860 — intervention group
Group type: COMPARATOR
Intervention: Parathyroidectomy (PTX)
Number of subjects: 167
Study 33097492 — intervention group
Group type: EXPERIMENTAL
Intervention: Autocratising countries
Number of subjects: 136
Study 35193510 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency obstetric care training (ALARM International Program)
Number of subjects: 577
Study 33139072 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted HSV infection
Number of subjects: 450581
Study 33125193 — intervention group
Group type: EXPERIMENTAL
Intervention: Difficulty awakening
Number of subjects: 237627
Study 33125193 — intervention group
Group type: EXPERIMENTAL
Intervention: Insomnia symptoms
Number of subjects: 237627
Study 33125193 — intervention group
Group type: COMPARATOR
Intervention: Migraine liability
Number of subjects: 237627
Study 32715866 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth intervention in pre-hospital and acute-care settings (n=11; 14.3%) for assessment and in rehabilitation and follow-up (n=61; 79.2%) for therapy delivery.
Number of subjects: 77
Study 34158840 — intervention group
Group type: EXPERIMENTAL
Intervention: Panitumumab-IRDye800 at low (50 mg) or high (100 mg) dose
Number of subjects: 11
Study 34158840 — intervention group
Group type: EXPERIMENTAL
Intervention: Panitumumab-IRDye800 at high (100 mg) dose
Number of subjects: 11
Study 34878625 — intervention group
Group type: EXPERIMENTAL
Intervention: LY-CovMab 30 mg, 150 mg, 600 mg, 1200 mg, 2400 mg
Number of subjects: 42
Study 34878625 — intervention group
Group type: EXPERIMENTAL
Intervention: LY-CovMab 150 mg
Number of subjects: 42
Study 34878625 — intervention group
Group type: EXPERIMENTAL
Intervention: LY-CovMab 600 mg
Number of subjects: 42
Study 34878625 — intervention group
Group type: EXPERIMENTAL
Intervention: LY-CovMab 1200 mg
Number of subjects: 42
Study 34878625 — intervention group
Group type: EXPERIMENTAL
Intervention: LY-CovMab 2400 mg
Number of subjects: 42
Study 34878625 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 34878625 — intervention group
Group type: EXPERIMENTAL
Intervention: LY-CovMab
Number of subjects: 42
Study 36050712 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorafenib maintenance
Number of subjects: 202
Study 36050712 — intervention group
Group type: COMPARATOR
Intervention: Control (non-maintenance)
Number of subjects: 202
Study 32770381 — intervention group
Group type: EXPERIMENTAL
Intervention: MP-MI/Physical lingual exercise (n = 8)
Number of subjects: 29
Study 32770381 — intervention group
Group type: COMPARATOR
Intervention: Physical lingual exercise (n = 7)
Number of subjects: 29
Study 32770381 — intervention group
Group type: COMPARATOR
Intervention: MP-MI lingual exercise (n = 7)
Number of subjects: 29
Study 32770381 — intervention group
Group type: COMPARATOR
Intervention: Placebo exercise (Control group, n = 7)
Number of subjects: 29
Study 34016349 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 min transition phase
Number of subjects: 9
Study 34016349 — intervention group
Group type: COMPARATOR
Intervention: 20 min transition phase
Number of subjects: 9
Study 34016349 — intervention group
Group type: COMPARATOR
Intervention: 45 min transition phase
Number of subjects: 9
Study 34016349 — intervention group
Group type: EXPERIMENTAL
Intervention: All transition phases (10, 20, 45 min)
Number of subjects: 9
Study 33176460 — intervention group
Group type: EXPERIMENTAL
Intervention: MitraClip (TMVr)
Number of subjects: 614
Study 33176460 — intervention group
Group type: COMPARATOR
Intervention: Control (GDMT only)
Number of subjects: 614
Study 35234160 — intervention group
Group type: EXPERIMENTAL
Intervention: Core Training Group (CTG)
Number of subjects: 24
Study 35234160 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 24
Study 32183772 — intervention group
Group type: EXPERIMENTAL
Intervention: COPe-support (digital mental health intervention)
Number of subjects: 360
Study 32183772 — intervention group
Group type: COMPARATOR
Intervention: Attention control (non-interactive online information resource pack)
Number of subjects: 360
Study 34039573 — intervention group
Group type: EXPERIMENTAL
Intervention: Casting in bayonet position
Number of subjects: 60
Study 32311960 — intervention group
Group type: EXPERIMENTAL
Intervention: Liang‐Xue‐Di‐Huang Decoction
Number of subjects: 0
Study 32311960 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 36176465 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram model for predicting cancer-specific survival (CSS)
Number of subjects: 970
Study 36176465 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram model
Number of subjects: 970
Study 36176465 — intervention group
Group type: EXPERIMENTAL
Intervention: Cox regression model
Number of subjects: 970
Study 33492208 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg of lansoprazole twice daily for 16 weeks
Number of subjects: 346
Study 33492208 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo for 16 weeks
Number of subjects: 346
Study 33492208 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg of lansoprazole for 12 months
Number of subjects: 346
Study 33492208 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo for 12 months
Number of subjects: 346
Study 33492208 — intervention group
Group type: COMPARATOR
Intervention: Lansoprazole and placebo
Number of subjects: 346
Study 33895386 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive direct anterior approach (DAA)
Number of subjects: 70
Study 33895386 — intervention group
Group type: COMPARATOR
Intervention: Direct lateral approach (DLA)
Number of subjects: 70
Study 33264302 — intervention group
Group type: EXPERIMENTAL
Intervention: B7A strain at 108 cfu with overnight fast
Number of subjects: 28
Study 33264302 — intervention group
Group type: EXPERIMENTAL
Intervention: B7A strain at 109 cfu with 90-minute fast
Number of subjects: 28
Study 33264302 — intervention group
Group type: EXPERIMENTAL
Intervention: B7A strain at 109 cfu with overnight fast
Number of subjects: 28
Study 33264302 — intervention group
Group type: EXPERIMENTAL
Intervention: B7A strain at 1010 cfu with 90-minute fast
Number of subjects: 28
Study 33264302 — intervention group
Group type: EXPERIMENTAL
Intervention: Rechallenge with B7A strain at 109 cfu with overnight fast
Number of subjects: 28
Study 33264302 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent challenge naïve subjects with B7A strain at 109 cfu
Number of subjects: 28
Study 36126995 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual CF care plus longitudinal palliative care intervention delivered by a palliative care specialist
Number of subjects: 264
Study 36126995 — intervention group
Group type: COMPARATOR
Intervention: Usual CF care alone
Number of subjects: 264
Study 36126995 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual CF care plus longitudinal palliative care intervention
Number of subjects: 264
Study 32207859 — intervention group
Group type: EXPERIMENTAL
Intervention: Autonomy support through dialogic learning (experimental group)
Number of subjects: 102
Study 32207859 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 102
Study 33752794 — intervention group
Group type: EXPERIMENTAL
Intervention: FENIX (magnetic sphincter augmentation device)
Number of subjects: 99
Study 33752794 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacral nerve stimulation
Number of subjects: 99
Study 33752794 — intervention group
Group type: COMPARATOR
Intervention: FENIX
Number of subjects: 99
Study 35297692 — intervention group
Group type: EXPERIMENTAL
Intervention: EMME + pauses (EMME + P)
Number of subjects: 195
Study 35297692 — intervention group
Group type: EXPERIMENTAL
Intervention: EMME without pauses (EMME-NoP)
Number of subjects: 195
Study 35297692 — intervention group
Group type: EXPERIMENTAL
Intervention: Pauses only (NoEMME + P)
Number of subjects: 195
Study 35297692 — intervention group
Group type: EXPERIMENTAL
Intervention: No EMME and no pause (NoEMME-NoP)
Number of subjects: 195
Study 34006539 — intervention group
Group type: EXPERIMENTAL
Intervention: Workers on workdays
Number of subjects: 190
Study 34006539 — intervention group
Group type: EXPERIMENTAL
Intervention: Workers on days off
Number of subjects: 190
Study 34006539 — intervention group
Group type: COMPARATOR
Intervention: Retirees on weekdays and weekend days
Number of subjects: 190
Study 33048635 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive video program of African American breast cancer survivor stories
Number of subjects: 108
Study 36174033 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% of one-repetition maximum (1RM) (low-load)
Number of subjects: 48
Study 36174033 — intervention group
Group type: EXPERIMENTAL
Intervention: 80% of one-repetition maximum (1RM) (high-load)
Number of subjects: 48
Study 34340986 — intervention group
Group type: EXPERIMENTAL
Intervention: EZ‐IO drill
Number of subjects: 92
Study 34340986 — intervention group
Group type: EXPERIMENTAL
Intervention: NIO‐I needle
Number of subjects: 92
Study 34340986 — intervention group
Group type: EXPERIMENTAL
Intervention: Jamshidi needle
Number of subjects: 92
Study 32278303 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel quantitative personal hygiene assessment tool
Number of subjects: 0
Study 32278303 — intervention group
Group type: COMPARATOR
Intervention: Conventional qualitative cleanliness metrics
Number of subjects: 0
Study 34391722 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal-Invasive Envelope Flap (MIEF)
Number of subjects: 34
Study 34391722 — intervention group
Group type: COMPARATOR
Intervention: Conventional Envelope Flap (CEF)
Number of subjects: 34
Study 34620620 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein-high fat with alcohol (0.7g/kg body weight, beer)
Number of subjects: 12
Study 34620620 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein-high fat without alcohol
Number of subjects: 12
Study 34620620 — intervention group
Group type: COMPARATOR
Intervention: Low protein-low fat without alcohol
Number of subjects: 12
Study 34620620 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol consumption with mixed meal
Number of subjects: 12
Study 36453045 — intervention group
Group type: EXPERIMENTAL
Intervention: Decompression with fusion
Number of subjects: 222
Study 36453045 — intervention group
Group type: COMPARATOR
Intervention: Decompression alone
Number of subjects: 222
Study 34765482 — intervention group
Group type: EXPERIMENTAL
Intervention: MTEI-(I) at 1 mL/kg/d (Group A)
Number of subjects: 40
Study 34765482 — intervention group
Group type: EXPERIMENTAL
Intervention: MTEI-(I) at 2 mL/kg/d (Group B)
Number of subjects: 40
Study 32896089 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic education, patient diary to mark daily medicine intake, and periodic telephone reminders
Number of subjects: 0
Study 32896089 — intervention group
Group type: COMPARATOR
Intervention: Usual standard of care
Number of subjects: 0
Study 35436911 — intervention group
Group type: EXPERIMENTAL
Intervention: Hearing aids intervention
Number of subjects: 385
Study 35436911 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 385
Study 32506663 — intervention group
Group type: EXPERIMENTAL
Intervention: MAPC treatment
Number of subjects: 10
Study 32796502 — intervention group
Group type: EXPERIMENTAL
Intervention: MARA + SMS
Number of subjects: 125
Study 32796502 — intervention group
Group type: EXPERIMENTAL
Intervention: MARA
Number of subjects: 125
Study 32796502 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 125
Study 33594827 — intervention group
Group type: EXPERIMENTAL
Intervention: Event-free survival (EFS) endpoint with conservative definition for treatment failure (TF) events
Number of subjects: 0
Study 33594827 — intervention group
Group type: EXPERIMENTAL
Intervention: Event-free survival (EFS) endpoint
Number of subjects: 0
Study 32133163 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based malaria case management using Learner Treatment Kits (LTK) providing malaria rapid diagnostic tests and artemisinin-based combination therapy.
Number of subjects: 9571
Study 32133163 — intervention group
Group type: COMPARATOR
Intervention: Control group (29 schools without the intervention).
Number of subjects: 9571
Study 33073629 — intervention group
Group type: EXPERIMENTAL
Intervention: Global health education framework
Number of subjects: 12
Study 33073629 — intervention group
Group type: EXPERIMENTAL
Intervention: Integration of global health education
Number of subjects: 12
Study 33073629 — intervention group
Group type: EXPERIMENTAL
Intervention: Global health competencies
Number of subjects: 12
Study 33073629 — intervention group
Group type: EXPERIMENTAL
Intervention: Challenges in global health education
Number of subjects: 12
Study 33073629 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarification of global health in rehabilitation
Number of subjects: 12
Study 33073629 — intervention group
Group type: EXPERIMENTAL
Intervention: Advancement of literature on global health in rehabilitation
Number of subjects: 12
Study 32221992 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance Exercise (EE) - cycling at 60% of peak power output for 50 minutes
Number of subjects: 24
Study 32221992 — intervention group
Group type: COMPARATOR
Intervention: Resistance Exercise (RE) - five exercise machines at 70% of the one-repetition maximum for 50 minutes
Number of subjects: 24
Study 34510024 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-month exercise intervention
Number of subjects: 89
Study 34510024 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 89
Study 32251253 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive task (Stroop's color-word conflict test)
Number of subjects: 30
Study 32251253 — intervention group
Group type: COMPARATOR
Intervention: Watching a documentary (control)
Number of subjects: 30
Study 35595003 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretomanid (doses: 50, 100, 200, 400, 600, 800, 1000 mg)
Number of subjects: 60
Study 35595003 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60